Literature DB >> 25850732

Onset of Mild Cognitive Impairment in Parkinson Disease.

David K Johnson1, Zachary Langford, Mauricio Garnier-Villarreal, John C Morris, James E Galvin.   

Abstract

OBJECTIVE: Characterize the onset and timing of cognitive decline in Parkinson disease (PD) from the first recognizable stage of cognitively symptomatic PD-mild cognitive impairment (PD-MCI) to PD dementia (PDD). Thirty-nine participants progressed from PD to PDD and 25 remained cognitively normal.
METHODS: Bayesian-estimated disease-state models described the onset of an individual's cognitive decline across 12 subtests with a change point.
RESULTS: Subtests measuring working memory, visuospatial processing ability, and crystalized memory changed significantly 3 to 5 years before their first nonzero Clinical Dementia Rating and progressively worsened from PD to PD-MCI to PDD. Crystalized memory deficits were the hallmark feature of imminent conversion of cognitive status. Episodic memory tasks were not sensitive to onset of PD-MCI. For cognitively intact PD, all 12 subtests showed modest linear decline without evidence of a change point.
CONCLUSIONS: Longitudinal disease-state models support a prodromal dementia stage (PD-MCI) marked by early declines in working memory and visuospatial processing beginning 5 years before clinical diagnosis of PDD. Cognitive declines in PD affect motor ability (bradykinesia), working memory, and processing speed (bradyphrenia) resulting in PD-MCI where visuospatial imagery and memory retrieval deficits manifest before eventual development of overt dementia. Tests of episodic memory may not be sufficient to detect and quantify cognitive decline in PD.

Entities:  

Mesh:

Year:  2016        PMID: 25850732      PMCID: PMC4592684          DOI: 10.1097/WAD.0000000000000088

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  45 in total

1.  Is PD-MCI a useful concept?

Authors:  Bruno Dubois
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

2.  Learning and consolidation of visuo-motor adaptation in Parkinson's disease.

Authors:  Lucio Marinelli; Domenica Crupi; Alessandro Di Rocco; Marco Bove; David Eidelberg; Giovanni Abbruzzese; M Felice Ghilardi
Journal:  Parkinsonism Relat Disord       Date:  2008-04-18       Impact factor: 4.891

3.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

5.  Statistical models for longitudinal biomarkers of disease onset.

Authors:  E H Slate; B W Turnbull
Journal:  Stat Med       Date:  2000-02-29       Impact factor: 2.373

6.  Parkinsonian patients without dementia or depression do not suffer from bradyphrenia as indexed by performance in mental rotation tasks with and without advance information.

Authors:  M E Duncombe; J L Bradshaw; R Iansek; J G Phillips
Journal:  Neuropsychologia       Date:  1994-11       Impact factor: 3.139

Review 7.  Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.

Authors:  Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre
Journal:  Mov Disord       Date:  2007-12       Impact factor: 10.338

8.  Change points in the series of T4 counts prior to AIDS.

Authors:  A S Kiuchi; J A Hartigan; T R Holford; P Rubinstein; C E Stevens
Journal:  Biometrics       Date:  1995-03       Impact factor: 2.571

9.  Course of cognitive decline in Parkinson's disease: a meta-analysis.

Authors:  Dino Muslimović; Ben Schmand; Johannes D Speelman; Rob J de Haan
Journal:  J Int Neuropsychol Soc       Date:  2007-11       Impact factor: 2.892

10.  Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.

Authors:  Tessandra Stewart; Changqin Liu; Carmen Ginghina; Kevin C Cain; Peggy Auinger; Brenna Cholerton; Min Shi; Jing Zhang
Journal:  Am J Pathol       Date:  2014-03-11       Impact factor: 4.307

View more
  9 in total

1.  When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.

Authors:  Justin E Karr; Raquel B Graham; Scott M Hofer; Graciela Muniz-Terrera
Journal:  Psychol Aging       Date:  2018-03

2.  Abnormal resting-state functional connectivity in posterior cingulate cortex of Parkinson's disease with mild cognitive impairment and dementia.

Authors:  Zhou-Wei Zhan; Li-Zhen Lin; Er-Han Yu; Jia-Wei Xin; Lin Lin; Hai-Long Lin; Qin-Yong Ye; Xiao-Chun Chen; Xiao-Dong Pan
Journal:  CNS Neurosci Ther       Date:  2018-03-03       Impact factor: 5.243

3.  Integrated case-based clinical approach in understanding pathways, complexities, pitfalls and challenges in neurodegenerative disorders.

Authors:  Aashitha Dhavala; Aditya Samitinjay; Praveen Khairkar; Vivek Podder; Amy Price; Syeda Hira Fatima; Rakesh Biswas
Journal:  Am J Neurodegener Dis       Date:  2022-06-20

4.  Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson's Disease.

Authors:  Junbeom Jeon; Kiyong Kim; Kyeongmin Baek; Seok Jong Chung; Jeehee Yoon; Yun Joong Kim
Journal:  J Mov Disord       Date:  2022-05-26

5.  Correlation of Visuospatial Ability and EEG Slowing in Patients with Parkinson's Disease.

Authors:  Dominique Eichelberger; Pasquale Calabrese; Antonia Meyer; Menorca Chaturvedi; Florian Hatz; Peter Fuhr; Ute Gschwandtner
Journal:  Parkinsons Dis       Date:  2017-02-28

Review 6.  Neurorehabilitation in Parkinson's Disease: A Critical Review of Cognitive Rehabilitation Effects on Cognition and Brain.

Authors:  María Díez-Cirarda; Naroa Ibarretxe-Bilbao; Javier Peña; Natalia Ojeda
Journal:  Neural Plast       Date:  2018-05-06       Impact factor: 3.599

7.  The Number Symbol Coding Task: A brief measure of executive function to detect dementia and cognitive impairment.

Authors:  James E Galvin; Magdalena I Tolea; Claudia Moore; Stephanie Chrisphonte
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

8.  Components determining the slowness of information processing in parkinson's disease.

Authors:  Aida Arroyo; José A Periáñez; Marcos Ríos-Lago; Genny Lubrini; Jorge Andreo; Julián Benito-León; Elan D Louis; Juan Pablo Romero
Journal:  Brain Behav       Date:  2021-01-15       Impact factor: 2.708

9.  Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease.

Authors:  Florian Lipsmeier; Kirsten I Taylor; Ronald B Postuma; Ekaterina Volkova-Volkmar; Timothy Kilchenmann; Brit Mollenhauer; Atieh Bamdadian; Werner L Popp; Wei-Yi Cheng; Yan-Ping Zhang; Detlef Wolf; Jens Schjodt-Eriksen; Anne Boulay; Hanno Svoboda; Wagner Zago; Gennaro Pagano; Michael Lindemann
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.